Cargando…

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study

PURPOSE: DA-8010 is a novel muscarinic M3 receptor antagonist with significant selectivity for bladder over salivary gland in preclinical studies. We evaluated the clinical efficacy and safety of DA-8010 in overactive bladder (OAB) patients. METHODS: This phase 2, randomized, double-blind, parallel-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Hee Seo, Oh, Cheol Young, Choo, Myung-Soo, Kim, Hyeong Gon, Kim, Joon Chul, Lee, Kyu-Sung, Shin, Dong Gil, Cho, Sung Yong, Jeong, Seong Jin, Seo, Ju Tae, Yoon, Hana, Moon, Hong Sang, Kim, Jang Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Continence Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260321/ https://www.ncbi.nlm.nih.gov/pubmed/35793990 http://dx.doi.org/10.5213/inj.2142382.191

Ejemplares similares

The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
por: Choi, Jin Bong, et al.
Publicado: (2020)

Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS)
por: Lee, Kyu Sung, et al.
Publicado: (2015)

Prevalence and Treatment Efficacy of Genitourinary Mycoplasmas in Women with Overactive Bladder Symptoms
por: Lee, Young-Suk, et al.
Publicado: (2010)

Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population
por: Oh, Seung-June, et al.
Publicado: (2012)

Effectiveness of Retropubic Tension-Free Vaginal Tape and Transobturator Inside-Out Tape Procedures in Women With Overactive Bladder and Stress Urinary Incontinence
por: Han, Ji-Yeon, et al.
Publicado: (2013)

Comparison of three fluids for calibration of the new Periotron® 8010
por: Fernández-Reyes, Meylin, et al.
Publicado: (2023)

A Randomized, Double-Blind, Placebo-Controlled, Bridging Study to Evaluate the Efficacy and Safety of Vibegron in Treating Korean Patients With Overactive Bladder
por: Shin, Jung Hyun, et al.
Publicado: (2023)

Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study
por: Song, Cheryn, et al.
Publicado: (2006)

Persistence and compliance with medication management in the treatment of overactive bladder
por: Kim, Tae Heon, et al.
Publicado: (2016)

Korean Translation and Linguistic Validation of Urgency and Overactive Bladder Questionnaires
por: Kim, Seung-Ee, et al.
Publicado: (2020)

Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction
por: Cho, Kang Jun, et al.
Publicado: (2015)

The Urologist's View of Male Overactive Bladder: Discrepancy between Reality and Belief in Practical Setting
por: Lee, Seung Hwan, et al.
Publicado: (2010)

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment
por: Kim, Aram, et al.
Publicado: (2017)

Diagnostic Value of the Maximum Urethral Closing Pressure in Women With Overactive Bladder Symptoms and Functional Bladder Outlet Obstruction
por: Kim, Su Jin, et al.
Publicado: (2022)

Safety, tolerability, and pharmacokinetics of single and multiple ascending Oral doses of DA‐8010 in healthy subjects: First‐in‐human phase I study
por: Lee, Dae Young, et al.
Publicado: (2023)

Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
por: Kim, Sung Dae, et al.
Publicado: (2017)

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study
por: Choo, M-S, et al.
Publicado: (2008)

Future directions in overactive bladder treatment: Personalized medicine can be applied?
por: Lee, Kyu-Sung
Publicado: (2015)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats
por: Ko, Il Gyu, et al.
Publicado: (2016)

Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy
por: Shin, Jung Hyun, et al.
Publicado: (2017)

Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study
por: Choi, Hoon, et al.
Publicado: (2018)

Autonomous Nervous System Activity in Women with Detrusor Overactivity
por: Im, Hyun Wook, et al.
Publicado: (2010)

The Impact of Overactive Bladder on Health-Related Quality of Life, Sexual Life and Psychological Health in Korea
por: Yoo, Eun Sang, et al.
Publicado: (2011)

Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design
por: Sung, Hyun Hwan, et al.
Publicado: (2020)

Role of Nicotinic Acetylcholine Receptor α3 and α7 Subunits in Detrusor Overactivity Induced by Partial Bladder Outlet Obstruction in Rats
por: Kim, Hyo Sin, et al.
Publicado: (2015)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Translation and Linguistic Validation of the Korean Version of the Treatment Satisfaction Visual Analogue Scale and the Overactive Bladder Satisfaction With Treatment Questionnaire
por: Lee, Ha Na, et al.
Publicado: (2017)

Correlation of Male Overactive Bladder with Intravesical Prostatic Protrusion
por: Kim, Ki Hong, et al.
Publicado: (2010)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study
por: Lee, Hahn-Ey, et al.
Publicado: (2013)

Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder
por: Kim, Sung-Eun, et al.
Publicado: (2012)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Clinical Factors Associated With Dose Escalation of Solifenacin for the Treatment of Overactive Bladder in Real Life Practice
por: Chun, Ji-Youn, et al.
Publicado: (2014)

Similar Operative Outcomes between the da Vinci Xi(®) and da Vinci Si(®) Systems in Robotic Gastrectomy for Gastric Cancer
por: Alhossaini, Rana M., et al.
Publicado: (2019)

Surgical Outcomes of Congenital Atrial Septal Defect Using da VinciTM Surgical Robot System
por: Kim, Ji Eon, et al.
Publicado: (2013)

Overactive Bladder is a Distress Symptom in Heart Failure
por: Son, Youn-Jung, et al.
Publicado: (2018)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Lee, Young-Suk, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k7sdt8t98p7hanmic6sbp9fb1f